A Membership Enables You To View All Industry & Peer Analysis

Benchmarked Fundamental Analysis (BFA)

Our Benchmarked Fundamental Analysis (BFA) entails examining the stocks you've designated and evaluating them against their industry and peer group. To ensure a fair comparison ... of equities from various global markets (such as Japan, Germany, UK ...), we standardize the currency denomination to the US Dollar. This means that all monetary values are converted using the prevailing bid/ask rate, such as from Japanese Yen (JPY) to US Dollars (USD). In the rare event that a particular forex is unavailable, we won't include it in your analysis.

Benchmarks

μ Industry μ Competition

Format

RAW In Mil.

Sheet/Category

Margins are presented in decimals *(e.g. 'NET PROFIT MARGIN' from 'Profitability')*.
	Free Cash Flow	Operating Cash Flow	Change In Working Capital	Based Compensation	Depreciation And Amortization	Net Cash Used For Investing Activites	Investments In Property Plant And Equipment	Net Cash Used Provided By Financing Activities	Sales Maturities Of Investments	Debt Repayment
GSK.L	5325	8442	-1138	408	3051	-2572	-3117	-6493	2533	-3152	6842	9845	360	460	3056	-11666	-3003	1094	1	-6147	6677	10576	-629	456	3356	-2363	-3898	-10093	23	-2653	8248	11226	159	448	829	2874	-2977	-13475	4347	-9715	7789	10666	706	485	3984	-7120	-2876	-2447	1	-6091	8811	11199	-328	478	2344	-2065	-2388	-8497	-601	-2641	6272	9200	-980	442	3964	-1919	-2928	-8485	5	-4256	5512	8641	-29	424	2475	-1687	-3128	-8501	908	-1222	888	3416	35	489	2476	8029	-2528	-9446	474	-3207	4555	6884	-121	441	2694	-1433	-2328	-7162	272	-2272	7342	9605	61	424	1881	696	-2262	-8343	78	-2489	3797	5818	528	292	1443	-3499	-2021	-4456	37	-3403	6546	8312	-2355	263	2230	-148	-1766	-8288	39	-10	6865	9040	3693	238	2754	-2484	-2174	-7409	156	-1783	7937	10428	-200	238	1690	-5337	-2491	-3689	430	-1058	6971	9723	91	2052	-2755	-2751	-5441	31	-4132	4857	7707	-715	1772	-4069	-2850	-1760	59	-275	3149	5264	-626	1513	-2116	-2114	-5749	42	-982	5859	7430	-414	1466	-1489	-1570	-4100	46	-1232	6000	6340	-606	1631	-1468	-339	-4065	77	-561	5040	6452	-581	1417	-1268	-1412	-1159	166	2437	4069	574	1208	-1489	-1631	-2864	163	-839	4643	6130	1102	1081	-3246	-1486	-3698	184	0.92	996	2463	395	977	-643	-1466	-726	658	-1005	-115	678	-369	569	-1191	-794	465	156	-11	-86	545	-734	476	-1103	-631	450	71	-83	266	817	-275	496	-873	-551	-78	295	-670	595	1129	-401	545	-138	-533	-875	3	-1669	755	1665	-61	708	-6374	-909	4862	49	-9695	2611	3257	-79	439	-6309	-645	2905	635	1400	66	375	-1812	-764	51	29	-2194	424	1232	5	299	-1141	-808	127	111	-2493	83	873	-97	254	-494	-790	-619	-2076	11	817	-154	200	-1131	-805	629	-2472
Drug Manufacturers—General	3944	5188	XXX X	XXX X	XXX X	XXX X	XXX X	XXX X	XXX X	XXX X
BP.L, NG.L, AZN.L, ULVR.L, VOD.L	4106	10502	XXX X	XXX X	XXX X	XXX X	XXX X	XXX X	XXX X	XXX X

More Categories

Capital Efficiency

Asset Turnover, ROA, ROE, ROIC (...)

Costs & Expenses

Cost of Income, Income Tax, Interest, Operating, R&D (...)

Debt Management

Debt Ratio, Debt/Equity, Debt/Assets, Total Debt/Capitalization (...)

Dividends

Payout Ratio, Yield (...)

Graham

Debt/Assets, Earnings Yield, NCAV, Graham Net, Graham Number, PB, PTB, PE

Inventory & Operational

Operating Cycle, DIO, DSI, Fixed Asset Turnover ...

Long-Term Growth (per Share)

10Y/5Y/3Y Revenue, 10Y/5Y/3Y Net Income, 10Y/5Y/3Y Dividend, 10Y/5Y/3Y Operating CF (...)

Create Your Own

Feature currently only available to certain members (pre-beta).

Benchmarked Fundamental Analysis (BFA)

ai interpretation

Menu

More Categories

Create Your Own